Trademark Updates

AI Chipmaker Groq Settles Trademark Suit Against Health-Tech Firm Groq Health in S.D.N.Y., Closing One Strand of ‘Groq/Grok’ Brand Disputes

U.S. AI chipmaker Groq Inc. resolved its trademark infringement suit against Groq Health Inc. on May 18, 2026, when the ...
IP News

Federal Circuit Reinstates Medtronic Ireland’s Counterclaims in Recor Medical Renal-Denervation Dispute, Applies A.L.M. Standing Framework

On May 19, 2026, the U.S. Court of Appeals for the Federal Circuit ruled in Recor Medical, Inc. v. Medtronic Ireland Man...
IP News

Federal Circuit Holds Sublicensing Veto, Royalty, and Right to Sue Together Satisfy Article III Standing in A.L.M. Holding v. Zydex

On May 19, 2026, the U.S. Court of Appeals for the Federal Circuit issued a precedential opinion in A.L.M. Holding Compa...
IP News

CJEU Sides with Italian Publishers in Meta v. AGCOM (C-797/23): Regulator-Led Fair Compensation Regime Held Compatible with EU Law

The Court of Justice of the European Union (CJEU) on 12 May 2026 ruled in Case C-797/23 that an Italian regime requiring...
IP News

USPTO Cracks Down on Inconsistent Claim Construction: Ford, Terumo BCT and TikTok PTAB Decisions Designated Informative

The United States Patent and Trademark Office (USPTO) on 13 May 2026 designated three decisions of the Patent Trial and ...
IP News

England’s Court of Appeal Endorses Nokia’s ‘Adjustable Licence Offers’ in RAND Dispute with Acer and ASUS – June Trial Halted

The Court of Appeal of England and Wales issued a landmark ruling on 12 May 2026 in Acer Incorporated & Anor v Nokia Tec...
IP News

CJEU Advocate General in Halozyme C-456/24: An Excipient Cannot Be Treated as an Active Ingredient for SPC Purposes

The Court of Justice of the European Union's Advocate General has issued an opinion in Halozyme, Case C-456/24, concludi...
IP News

USPTO Data Failure Hid 1.4 Million Patent Assignment Records – Including 450,000 Real-Ownership Transfers

Roughly 1.4 million patent assignment records held by the U.S. Patent and Trademark Office sat outside public view for y...
IP News

USPTO Director Squires Issues Precedential Discretionary Denial in Magnolia Medical IPR – Targeting Litigation Leverage

USPTO Director John Squires issued a Director Discretionary Decision on May 14, 2026, denying institution of an inter pa...
IP News

Federal Circuit Affirms ‘pH 13 or Higher’ Means ‘pH 12.98 or Higher’ in Actelion v. Mylan: Generic Epoprostenol Cleared of Infringement

The Federal Circuit on May 13, 2026 affirmed Mylan's generic epoprostenol does not infringe Actelion's Veletri patents, holding 'pH of 13 or higher' means 'pH 12.98 or higher' and foreclosing the doctrine of equivalents under both prosecution history estoppel and the disclosure-dedication rule.